For research use only
| Cat No. | ABC-TC3495 |
| Product Type | Vascular Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Aortic Endothelial Cells-Diabetic Type I ,Primary endothelial cells from diabetic type I donors; model for vascular biology and metabolic disease.
Human Aortic Endothelial Cells-Diabetic Type I are primary cells isolated from the descending aorta (arch to the renal artery) of confirmed Type 1 diabetic human donors. Following primary culture, these cells are cryopreserved. These cells, as the key cellular component of the human aortic endothelium, exhibit characteristic cobblestone morphology. These cells regulate vascular tone and barrier integrity but exhibit hallmark diabetic hyperglycemia-induced dysfunction including impaired nitric oxide synthesis, elevated ROS production, and sustained RAGE/NF-κB-mediated inflammation. These cells have been identified as critical contributors to diabetic vasculopathy, including accelerated atherosclerosis, aortic calcification, hypertension, and microvascular complications like nephropathy and retinopathy. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Aortic Endothelial Cells Type I Diabetes, HAoECs T1DM, Aortic Endothelial Cells Diabetic Type I, Human Aorta ECs T1DM, Diabetic Type I Aortic ECs |
| Species | Human |
| Cat.No | ABC-TC3495 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Aortic Endothelial Cells-Diabetic Type I serve as a pathophysiologically relevant in vitro model to study diabetic vasculopathy in conditions like accelerated atherosclerosis and microangiopathy. Their disease-specific responsiveness enables detailed study of RAGE/NF-κB signaling pathways, particularly in hyperglycemia-induced ICAM-1 upregulation and monocyte adhesion. Researchers can utilize this model to screen advanced glycation end-product (AGE) inhibitors, evaluate NO-boosting therapies targeting plaque progression and develop targeted interventions for diabetic plaque progression and microvascular complications affecting renal and retinal tissues. The cells serve as a crucial translational bridge between basic diabetic vascular research and therapeutic development.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).